Perspectives in 2023

Filter By:

Article Type
Year
  • The current definition of myocardial infarction is applied inconsistently, with implications for patients and research; here, the authors propose a new definition and call for further research and consensus.

    • Bertil Lindahl
    • Nicholas L. Mills
    Perspective
  • As the proportion of older adults increases globally, digital health innovations, particularly wearables, could transform the future of healthy aging.

    • Chuanrui Chen
    • Shichao Ding
    • Joseph Wang
    Perspective
  • The recently completed NCI-MATCH is one of the largest precision oncology trials undertaken to date; this Perspective discusses key aspects of its design and conduct, and lessons for future precision oncology studies.

    • Peter J. O’Dwyer
    • Robert J. Gray
    • James H. Doroshow
    Perspective
  • The health sector must play its part in decarbonization efforts; this Perspective outlines the principles of fair pathways to net-zero healthcare that are attentive to health and socioeconomic inequalities.

    • Anand Bhopal
    • Ole F. Norheim
    Perspective
  • This Perspective outlines practical considerations for designing and testing visual displays to communicate health information, using illustrative case examples.

    • Steven Woloshin
    • Yanran Yang
    • Baruch Fischhoff
    Perspective
  • The authors describe a localized toxicity syndrome that is associated with immunotherapy treatment for CNS tumors and propose a new grading scale—with the goal of promoting research and standardizing both reporting and management.

    • Jasia Mahdi
    • Jorg Dietrich
    • Michelle Monje
    Perspective
  • Moving away from the traditional ‘tumor-centric’ view, the authors explore how systemic biology, as well as aging, co-morbidities and co-medications, all interact and influence cancer development and progression.

    • Guido Kroemer
    • Jennifer L. McQuade
    • Laurence Zitvogel
    Perspective
  • Technological advances are transforming evidence generation in medicine; for these advances to impact public health, the clinical trial landscape must evolve and adapt to keep pace.

    • Vivek Subbiah
    Perspective